Director
Merck
Dr. Dan Li, PhD, is currently a Director in Quantitative pharmacology and pharmacometrics (QP2) group at Merck. She earned her PhD degree from the University of Michigan and then joined Merck as a senior scientist. She has research expericences in antibacterial drug development and her current research focus on clinical pharmacology in cardiovascular and ophthalmology areas. She has been a member of ASCPT since 2018 and has served on the ASCPT infectious disease committee and selected as the member of ASCPT's inaugural leadership accelerator cohort.